The Covid-19 vaccine Comirnaty is being recommended for 12 to 15-year-olds

The European Medicines Agency (EMA) recommends that the COVID-19 vaccine Comirnaty, which is manufactured by the pharmaceutical company Pfizer-BioNTech, be approved for 12 to 15-year-olds.

The decision is based on a study that involved 2,260 adolescents aged between 12 and 15, writes the Swedish Medical Products Agency.

The European Commission will now make a formal decision regarding its approval. The Public Health Agency of Sweden is responsible for recommendations on the use of Covid-19 vaccines in Sweden.

Comirnaty (Pfizer-BioNTech) was approved by the European Commission on 21 December 2020, and is a vaccine used for the prevention of Covid-19 caused by the SARS-CoV-2 virus. Comirnaty is currently approved for use in adults and adolescents aged 16 and older. The vaccine helps the immune system (the body’s own defence mechanism) to start producing antibodies against the virus, which help the body to defend itself against Covid-19.

You can read more about the underlying study on the Swedish Medical Products Agency’s website via the link below.

Source: SwedishMedicalProductsAgency

Tags for this page: